directmeds tirzepatide Flex-Dose 1 mL Injectable 10 mg/mL Microdosing Tirzepatide Program | No

Safety Concerns The proliferation of compounded GLP-1s was accompanied by safety concerns, largely because compounded drugs were not reviewed by the FDA prior to distribution

Int J Obes 2005

Manuel Jurado, principal at consulting firm the Dedham Group, told Healthcare Brew that coverage could lead to overall cost savings in the future, as GLP-1s have been shown to reduce the odds of developing chronic illnesses like diabetes and cardiovascular disease

You wouldnt know it from the most cheerleading business coverage of GLP-1s, but the drugs revenue growth has actually come in below market expectations in the last few years

This highlights the importance of swift medical intervention if you suspect you or someone else has taken an excessive dose of Ozempic

10.1038/srep21164 4 BewleyM